Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Caitlin E. Cox

October 11, 2017

News Conference News PCR London Valves 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

Higher Burden of Medicaid and Uninsured Patients Means Hospitals Less Likely to Rescue After Trouble in Abdominal Aortic Surgery

News Daily News

More ‘Safety-Net’ Patients, Fewer Saves When Abdominal Aorta Surgery Goes Awry

Ashley Lyles

July 27, 2017

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Caitlin E. Cox

March 31, 2017

Presentation SIF 2017

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

Presenter: Robert D. Riley

March 11, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Valve Deterioration and Durability Definitions Now Standardized in New Guide

TAVR in the US: Regional Variations in Numbers, Outcomes

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

More ‘Safety-Net’ Patients, Fewer Saves When Abdominal Aorta Surgery Goes Awry

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Cardiologists "Need" the Surgeons to Optimize the Quality of Their Structural Heart Program

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content